OBJECTIVES:   Upon completion of this activity, the participant should be able to:
1. Review the development of noninvasive rejection surveillance tools. 
2. Analyze current status of these tools. 
3. Identify future potential usages of these tools. 

FACULTY DISCLOSURE: Shelley A. Hall, MD, FACC, FHFSA, FAST serves as a consultant for Abbott, Abiomed, Evaheart, CareDX and Natera. 

PLANNERS DISCLOSURE: Ramachandra Reddy, MD and Robert Widmer, MD have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact [email protected] 

Meeting Link: